about
Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57Endocrine disrupting chemicals: a new and emerging public health problem?European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society Consensus Statement on Diabetic Ketoacidosis in Children and AdolescentsSimulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetes.Cerebral edema in children with diabetic ketoacidosis: vasogenic rather than cellular?Anogenital distance from birth to 2 years: a population studyMaternal but not paternal association of ambulatory blood pressure with albumin excretion in young offspring with type 1 diabetesEffects of growth hormone and free fatty acids on insulin sensitivity in patients with type 1 diabetes.Cystic fibrosis related diabetes mellitus - diagnostic and management challenges.Breastfeeding and infant temperament at age three months.Survey of adrenal crisis associated with inhaled corticosteroids in the United KingdomManual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial.Auxological changes in UK survivors of childhood acute lymphoblastic leukaemia treated without cranial irradiation.Lipidomic analyses, breast- and formula-feeding, and growth in infants.Anogenital distance and penile length in infants with hypospadias or cryptorchidism: comparison with normative data.Working memory performance is reduced in children with congenital adrenal hyperplasiaESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents.Associations between paternally transmitted fetal IGF2 variants and maternal circulating glucose concentrations in pregnancy.Meta-analysis of overnight closed-loop randomized studies in children and adults with type 1 diabetes: the Cambridge cohortAge at Weaning and Infant Growth: Primary Analysis and Systematic ReviewValidity of triple- and dual-tracer techniques to estimate glucose appearance.Childhood and adolescent diabetes.Home Use of an Artificial Beta Cell in Type 1 DiabetesA family with severe insulin resistance and diabetes due to a mutation in AKT2.Evaluating the accuracy and large inaccuracy of two continuous glucose monitoring systems.Transient neonatal diabetes, ZFP57, and hypomethylation of multiple imprinted loci: a detailed follow-upHypopituitarism in childhood and adolescence following traumatic brain injury: the case for prospective endocrine investigation.Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial.Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trialUltrasound estimates of visceral and subcutaneous-abdominal adipose tissues in infancy.Traumatic brain injury induced hypothalamic-pituitary dysfunction: a paediatric perspective.Pregnancy insulin, glucose, and BMI contribute to birth outcomes in nondiabetic mothersPrevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetesInsulin sensitivity assessed by stable isotopes with oral glucose administration: validation with euglycaemic clamp.Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studiesAn Unbiased Lipidomics Approach Identifies Early Second Trimester Lipids Predictive of Maternal Glycemic Traits and Gestational Diabetes Mellitus.Pegvisomant: current and potential novel therapeutic applications.Hypoglycaemia following diabetes remission in patients with 6q24 methylation defects: expanding the clinical phenotype.Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial.How to use near-patient capillary ketone meters.
P50
Q24312925-89FA4CCC-2B3B-4DEC-BB69-590723DB4C58Q24675232-C1408CA4-EAB6-4305-B9AA-4B50D544B670Q28109710-0443DFB7-4027-43B8-8371-F3364E8A9888Q30433675-5AB1C28C-A5F6-4CD4-91E2-C975A8AD4D79Q30827090-B08C36A5-EF6B-42B4-BCC0-54B2E48FDE1FQ33569415-0D79BE5C-A99E-4A42-A0CE-601A630AC557Q33602292-E7FA7EB7-30B9-4F80-8966-A51A98B0836BQ33759055-93C3E9A0-CA08-4AB9-87EB-9173EB24FDDEQ34089920-CB47B933-D327-4F1F-B6BF-6572F25A8D4BQ34130361-ADEF6616-8170-47C7-A6EC-F74B3CC382AEQ34161394-65425923-09EB-494E-AEC2-E9998DA67E94Q34616506-E671F506-2474-42AE-A2B3-970787651AC1Q34621846-B164293F-7C1B-4986-9478-3BAC10176E75Q34996689-F83DD147-D0F8-4640-9B42-D97E15584560Q35062329-F4628371-2A27-4DB9-B85A-3074BB8449FCQ35095127-9CA106DF-5484-4CEE-8DB4-29993888358DQ35278328-2D713F3C-8093-4161-B67C-C396910025C2Q35404836-32963254-DF93-4928-8422-D618445354F3Q35684916-41D5DDBA-4F68-4938-B5BE-043F55AE5ADBQ35904874-C64976AF-8A6C-4CE1-9DE9-7D120E0498DFQ36042126-8139AA02-8121-41B2-9D1C-1AAD1655A3D6Q36119554-0A1A8921-6D53-42A8-A5CD-8E64363E35D0Q36419734-F2421C80-5D23-4265-9178-A22FD2309706Q36481707-F8AF42F6-9DF6-4FBD-8104-6B8BAEC485DDQ36572849-A2775E32-F852-4D7C-A882-39BF06AF35DBQ36629581-D5838247-3D9F-40E7-94AD-8F721889DC41Q36633887-5CA420C5-87C7-4C64-89A4-32817102B6BDQ36720273-48DBC07F-0A89-4ED0-9EEF-55FD22B0111EQ36800053-BDE44988-00FB-4368-A017-8C75F24B0579Q36844994-1C5EF21A-55CB-4590-B255-3CCE49C03E03Q36849768-AB4690AB-92C0-43FE-9838-18296D43E760Q36945231-C2099246-6BEA-40C6-B4BF-75EFAC4D9EBBQ37139501-CBB06661-7C41-40F6-A495-EC4946FC0A5BQ37394534-FB2861BB-1BB8-4DE4-94B8-294C55A823B0Q37404440-A58BB3FD-D602-490D-BDD4-BC539A987AA3Q37441548-8FBC245C-3DF5-48A7-B953-D5287FC58DF2Q37633543-D7B1C2FA-4C4A-4796-8D23-1ACB4F3B0B94Q37696626-9DA2A3C3-0942-45B6-A559-F9FCB02F5292Q37715553-1BDFBC4C-50F2-4D7B-A7ED-5B86493B559AQ38028457-3D262178-B8BA-434C-BE69-4B804BE07D24
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Carlo L Acerini
@ast
Carlo L Acerini
@en
Carlo L Acerini
@es
Carlo L Acerini
@nl
Carlo L Acerini
@sl
type
label
Carlo L Acerini
@ast
Carlo L Acerini
@en
Carlo L Acerini
@es
Carlo L Acerini
@nl
Carlo L Acerini
@sl
altLabel
Carlo Acerini
@en
prefLabel
Carlo L Acerini
@ast
Carlo L Acerini
@en
Carlo L Acerini
@es
Carlo L Acerini
@nl
Carlo L Acerini
@sl
P106
P21
P31
P496
0000-0003-2121-5871